The German Biotechnology Sector 2016

The German Biotechnology Sector 2016

The report provides an overview to the current status of the German biotechnology sector.
More revenue, more jobs, more financing, more R&D expenditure - all signs point towards sustainable growth in the German biotech sector. These are the results of the most recent company survey 2016.

The report was once again conducted alongside the biotech standards defined by the organisation for economic cooperation and development (OECD).

© biotechnologie.de; Berlin, 2016

Nachrichten unserer Mitglieder

  • BSB würdigt Symrise-Produkte SymGuard® CD und SymControlTM Care mit Innovationspreis

    Symrise AG 6.08.2018Mehr
  • MyBio Adopts Genedata for Improving Antibiotic Production Processes

    Genedata GmbH10.07.2018Mehr
  • Klaus Pellengahr neuer Geschäftsführer bei Organobalance-Novozymes Berlin. Gründerin Prof. Dr. Christine Lang bleibt dem Unternehmen als Beraterin verbunden

    Organobalance GmbH 2.07.2018Mehr
  • Alle Links